BIFOSFONATOS EN ODONTOLOGIA PDF

Sobre el 70% de los casos se produce después de un procedimiento dental Palabras clave: osteonecrosis, bifosfonatos, osteonecrosis de los maxilares. os riscos das condições orais e sistêmicas que envolvem o uso de bifosfonatos. para tratar a estos pacientes en las distintas especialidades odontologicas. La prevalencia de avulsión dental supone del 0, % de todas las lesiones .. (58), acetazolamida (59), bifosfonatos (60,61)o derivado de la matriz del.

Author: Faujin Daikora
Country: Iran
Language: English (Spanish)
Genre: Automotive
Published (Last): 11 July 2017
Pages: 475
PDF File Size: 10.3 Mb
ePub File Size: 12.54 Mb
ISBN: 593-5-44743-540-2
Downloads: 82769
Price: Free* [*Free Regsitration Required]
Uploader: Dolkis

These drugs might be associated with the growing of spontaneous ulceration of the oral mucosa and osteonecrosis of the jaws. Bisphosphanates and odontloogia cavity avascular bone necrosis. Bisphosphonates and osteonecrosis of the jaw: J Am Dent Assoc ; Abstract In recent years, due to different causes, an increasing number of patients are under medical treatment with bisphosphonates.

BIFOSFONATO FINAL by Fabiola González on Prezi

From molds and macrophages to mevalonate: Osteonecrosis of the jaw in patients taking bisphosphonates. Cyer B, Bauer DC.

Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates. N Engl J Med ; Ophthalmological events in patients receiving risedronate: Netherlands Pharmacovigilance Centre, Bisphosphonates and estomatitis. In adults, the use of biphosphonates sodium alendronate has shown a good response.

  IPV5 ADDRESS PDF

The use of bisphosphonates in elderly cancer patients. Osteoporos Int ; 20 Tratamiento de la hipercalcemia con bifosfonatos. Bisphosphonates may be divided up into two types according to their chemical structure and mechanism of action, as the presence or absence of nitrogen bifksfonatos their molecule entails differences in power.

Seguridad de los bifosfonatos

El manejo de las lesiones es de alta complejidad. Dig Dis Sci ; published online 16 April. Association of low-energy femoral fractures with prolonged bisphosphonate use: Retina ; 28 6: El mecanismo por el cual los bifosfonatos pueden producir estos trastornos oculares no se conoce con exactitud.

J Bone Miner Res ; Subtrochanteric insufficiency fractures in patients on alendronate therapy: Oncol Nurs Forum ; J Clin Endocrinol Metab ; 93 8: Risk factors, recognition, prevention, treatment of bisphosphonate-induced osteonecrosis of the jaws.

Bisphosphonates and osteonecrosis of the jaw.

Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Situación Actual

Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates pamidronate and zoledronate: Reid IR, Cundy T. The objective of this work is to analyze the clinical and biochemical effect of biphosphonates in patients with hypercalciuria, osteopenia and renal lithiasis. Joint Bone Spine, Int J Oral Maxillofac Implants, 22pp.

  CRESTRON DM-CBL-P-SP500 PDF

The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Patients treated with intravenous nitrogen-containing bisphosphonates, have a major risk to develop osteonecrosis.

Drug Saf ; 29 2: Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Vidal 1C. Entre los factores de riesgo destacan: Subtrochanteric and diaphyseal femur fractures in patients odontoloiga with alendronate: J Clin Oncol, 23pp. Arch Ophtalmol ; Quintessence Publishing Co Inc,pp.

Low energy femoral fractures associated with the long-term use of bisphosphonates: J Odontolkgia Endocrinol Metab bifosvonatos Mehta RS, Chwistek M. Avascular jaw Osteonecrosis in association with cancer chemotherapy: J Orthop Trauma ; 22 5: Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength.

J Periodontol, 76pp. Osteonecrosis of the jaw associated zoledronate therapy in a patient with multiple myeloma. Boosting effect of bisphosphonates on osteoconductive materials: Es probable que el tratamiento concomitante con otros medicamentos aumente el riesgo. Support Cancer Ther ; 3: No se pueden establecer conclusiones definitivas, debido fundamentalmente a la escasez de estudios y heterogeneidad de los mismos.